Atlantic Pharmaceuticals Inc., University of Pennsylvania deal

ATLC subsidiary Channel Therapeutics Inc. terminated its 1994 license agreement with the university, returning all rights to the university's Beta-cyclodextrin tetradecasulfate (B-CDT) technology to p...